Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
08/07/2003 | US20030149238 Novel compounds |
08/07/2003 | US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents |
08/07/2003 | US20030148949 Administering a trefoil peptide or biologically active fragment thereof to a skin lesion or region of the skin where a lesion is to be prevented; wound healing agents which can speed healing, reduce pain and delay/prevent lesions |
08/07/2003 | US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders |
08/07/2003 | US20030148943 Novel tachykinin-like polypeptides and use thereof |
08/07/2003 | US20030148936 Bioactive peptides |
08/07/2003 | US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders |
08/07/2003 | US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents |
08/07/2003 | US20030148529 Utilization of invertebrate learning for flexible and sensitive monitoring and identification of chemicals |
08/07/2003 | US20030148523 Transporting material through membranes of cells in trehalose culture; genetic engineering |
08/07/2003 | US20030148517 Preparation and compositions for antrodia camphorata mycelium biologically active material |
08/07/2003 | US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells |
08/07/2003 | US20030148500 Transcription factor |
08/07/2003 | US20030148499 Media and methods for cultivation of microorganisms |
08/07/2003 | US20030148498 Microorganism overproducing 5'-xanthylic acid |
08/07/2003 | US20030148497 Bacteriolytic complex, method for producing said complex and strain for carrying out said method |
08/07/2003 | US20030148495 Useful mutations of bacterial alkaline protease |
08/07/2003 | US20030148494 Nucleotide sequences coding methylomonas pyrophosphate dependent phosphofructokinase (PDP) for preparing heterpolysaccharide; food thickeners; supension agents for pesticides and paints |
08/07/2003 | US20030148487 1,3-dicarbonyl-dioxygenase - a new c-c-bond cleaving enzyme |
08/07/2003 | US20030148482 Method for producing xylitol |
08/07/2003 | US20030148479 Biosynthesis of isopentenyl pyrophosphate |
08/07/2003 | US20030148478 Such as nicotinamide, via extract of nitrile hydratase from Amycolatopsis, Actinomadura and/or Rhodococcus |
08/07/2003 | US20030148476 Nucleotide sequences that code for the rplK gene and methods of use thereof |
08/07/2003 | US20030148475 Mutant N-acetylglutamate synthase and method for L-arginine production |
08/07/2003 | US20030148474 Modified glutamine synthetase expressed in Escherichia for biosynthesis of glutamine, arginine, tryptophan, histidine and glutamate; for assimilation of ammonia |
08/07/2003 | US20030148473 Method for producing L-amino acid using bacteria belonging to the genus escherichia |
08/07/2003 | US20030148472 Comprises nucleotide sequences coding hydantoinase/hydrolases for producing pharmaceuticals, chemical industrial products and food |
08/07/2003 | US20030148469 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
08/07/2003 | US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases |
08/07/2003 | US20030148464 Comprises nucleotides sequences contained in expression vector which code mutant hydrolase with reduced activity and additional heterologous polypeptides |
08/07/2003 | US20030148461 Comprises genetically engineered subtilisin regulatory sequence for increasing expression of heterologous proteins such as proteases, lipases and amylases in bioreactors/trangenic cells |
08/07/2003 | US20030148459 Comprises nucleotide sequences coding glycosyltransferases/acyltransferases for lipid A biosynthesis and ganglioside mimetics; prevention pathogen infections |
08/07/2003 | US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
08/07/2003 | US20030148455 Apo-2 receptor |
08/07/2003 | US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor |
08/07/2003 | US20030148446 Acute neuronal induced calcium binding protein type 1 ligand |
08/07/2003 | US20030148444 Sodium-independent small neutral amino acid transporters transporting L- and D-amino acids and genes thereof |
08/07/2003 | US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them |
08/07/2003 | US20030148441 Method for preparing polypeptide variants |
08/07/2003 | US20030148440 Preparing hydroxynitrilase for generation of cyanohydrins; disease resistant plants |
08/07/2003 | US20030148422 Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases |
08/07/2003 | US20030148421 Comprises nucleotide sequences coding pancreatic polypeptides for use in treatment of diabetes and insulin resistance; drug screening |
08/07/2003 | US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
08/07/2003 | US20030148418 Proteolytic fermenter |
08/07/2003 | US20030148416 Isoprenoid production |
08/07/2003 | US20030148414 Comprises extracellular bacterial autoinducer-2 signalling molecule (such as 4,5-dihydroxy-2,3-pentanedione or homocysteine) which stimulates LuxQ bioluminescent proteins/ genes in Vibrio harveyi operon bioassay |
08/07/2003 | US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors |
08/07/2003 | US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
08/07/2003 | US20030148389 Schizophrenia related gene and protein |
08/07/2003 | US20030148388 Patched genes and uses related thereto |
08/07/2003 | US20030148378 Phosphodiesterase 10 |
08/07/2003 | US20030148356 Amyloid precursor protein (APP); secretases |
08/07/2003 | US20030148355 Gene expression levels indicate sleep disorders |
08/07/2003 | US20030148346 Comprises Staphylococcus aureus virulence genes which target bactericides in assay; drug screening; vaccines |
08/07/2003 | US20030148330 Enhancing domains; polymerases; thermal stability |
08/07/2003 | US20030148325 Infectious clones |
08/07/2003 | US20030148324 Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides |
08/07/2003 | US20030148306 Aggrecanase molecules |
08/07/2003 | US20030148305 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
08/07/2003 | US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein |
08/07/2003 | US20030148265 The factor allowing translocation is the homeodomain of antennapedia, and the viral protein can be from Flavivirus; fusion proteins as therapeutic agents |
08/07/2003 | US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions |
08/07/2003 | US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof |
08/07/2003 | US20030147914 Inactivated, whole or partial Mycoplasma bovis cell and a pharmaceutically acceptable carrier; for cattle |
08/07/2003 | US20030147913 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family |
08/07/2003 | US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture |
08/07/2003 | US20030147903 ABC transport polynucleotides, polypeptides and antibodies |
08/07/2003 | US20030147897 M. tuberculosis antigens |
08/07/2003 | US20030147893 Novel human transmembrane 4 superfamily protein |
08/07/2003 | US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy |
08/07/2003 | US20030147858 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
08/07/2003 | US20030147856 Proteins |
08/07/2003 | US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells |
08/07/2003 | CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof |
08/07/2003 | CA2474908A1 Aggrecanase molecules |
08/07/2003 | CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
08/07/2003 | CA2474759A1 Gene for peripheral arterial occlusive disease |
08/07/2003 | CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/07/2003 | CA2474639A1 Mutant actinosynnema pretiosum strain with increased maytansinoid production |
08/07/2003 | CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them |
08/07/2003 | CA2463476A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
08/06/2003 | EP1333095A1 Process for the reversible functional inactivation of the mismatch repair system |
08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
08/06/2003 | EP1333092A2 28 human secreted proteins |
08/06/2003 | EP1333091A1 Novel disease-associated gene and use thereof |
08/06/2003 | EP1333085A2 Cell-cultivating device |
08/06/2003 | EP1333035A2 Growth differentiation factor-8 |
08/06/2003 | EP1332226A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma |
08/06/2003 | EP1332222A2 Metabolic rate shifts in fermentations expressing recombinant proteins |
08/06/2003 | EP1332217A2 Novel bacterial phytases and method for producing same |
08/06/2003 | EP1332216A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
08/06/2003 | EP1332209A2 Collections of repeat proteins comprising repeat modules |
08/06/2003 | EP1332157A2 Prokineticin polypeptides, related compositions and methods |
08/06/2003 | EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
08/06/2003 | EP1332155A2 Immunization of dairy cattle with gapc protein against streptococcus infection |
08/06/2003 | EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp |
08/06/2003 | EP1332153A1 Human ect2 and methods of use |
08/06/2003 | EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds |
08/06/2003 | EP0833943B1 Method for identifying secretory genes in helicobacter pylori |
08/06/2003 | EP0728018B1 New enzymes and prodrugs for ADEPT |